MICA and non-small cell lung carcinoma: We previously showed that MICA/B overexpression in NSCLC cells was independently associated with a good prognosis in terms of RFS, and the updated data showed that MICA/B overexpression is useful for the prediction of improved clinical outcomes in terms of both RFS and OS.